Synthesis of Fused Polycyclic Aromatics
J. Am. Chem. Soc., Vol. 119, No. 20, 1997 4589
(t, 6H, J ) 6.8 Hz), 1.1-1.5 (36H), 1.75 (m, 4H), 3.87 (s, 6H), 3.93
(t, 4H, J ) 6.70 Hz), 6.80 (d, 4H, J ) 8.66 Hz), 7.00 (d, 4H, J ) 8.66
Hz), 7.28 (d, 4H, J ) 8.66 Hz), 7.63 (s, 2H), 7.67 (d, 4H, J ) 8.63
Hz). 13C NMR (125 MHz, CDCl3): δ 14.12, 22.68, 26.00, 29.18, 29.37,
29.58, 29.62, 31.91, 55.35, 68.10, 88.19, 93.73, 113.38, 114.54, 115.25,
121.51, 130.47, 132.21, 132.85, 133.44, 141.24, 159.26, 159.27. UV-
vis (CHCl3) λmax (ꢀ, cm-1 M-1): 368 (sh, 40 100), 344 (44 600), 298
(50 000) nm. Luminescence spectrum (CHCl3) λmax (rel intensity): 382
(1), 398 (0.83) nm. HRMS (FAB): found m/z 858.5549 (M+); calcd
for C60H74O2 m/z 858.5587.
2′,5′-Bis((4-(dodecyloxy)phenyl)ethynyl)-2,5,2′′,5′′-tetramethyl-
[1,1′:4′,1′′]terphenyl (5). Compound 5 was prepared as described for
compound 2, substituting 2,5-(dimethyl)phenylboronic acid for 2,5-
(dimethoxy)phenylboronic acid. Compound 5 was obtained as a white
solid in 85.4% yield (mp 164-167 °C). 1H NMR (250 MHz, CDCl3):
δ 0.88 (t, 6H, J ) 6.8 Hz), 1.1-1.5 (36H), 1.75 (m, 4H), 2.26 (s, 6H),
2.37 (s, 6H), 3.90 (t, 4H, J ) 6.53 Hz), 6.75 (d, 4H, J ) 8.80 Hz),
7.07 (d, 4H, J ) 8.75), 7.11-7.21 (m, 6H), 7.49 (s, 2H). 13C NMR
(62.9 MHz, CDCl3): δ 14.12, 19.57, 20.97, 22.68, 25.98, 29.14, 29.35,
29.58, 31.91, 68.00, 87.73, 93.83, 114.40, 115.12, 112.57, 128.28,
129.57, 130.59, 132.32, 132.81, 133.34, 134.56, 139.81, 143.02, 159.14.
UV-vis (5-C4 (butoxy replaces dodecyloxy), CHCl3) λmax (ꢀ, cm-1
M-1) 364 (sh, 61 200), 342 (63 900) nm. Luminescence spectrum
(CHCl3) λmax (rel intensity): 372 (1), 390 (0.77) nm. HRMS (FAB):
found m/z 854.6008 (M+); calcd for C62H78O2 m/z 854.6002.
sity): 374 (0.58), 442 (1) nm (very low intensity). HRMS (FAB):
found m/z 1170.3802 (M+); calcd for C62H76O6I2 m/z 1170.3731. Anal.
Calcd for C62H76O6I2: C, 63.59; H, 6.54. Found: C, 63.51; H, 6.59.
Preparation of 5,12-Bis(4-(dodecyloxy)phenyl)-1,4,8,11-tet-
ramethoxydibenz[a,h]anthracene (6) from 5,12-Bis(4-(dodecyloxy)-
phenyl)-6,13-diiodo-1,4,8,11-tetramethoxydibenz[a,h]anthracene (7).
A solution of 7 (0.005 g, 0.004 mmol) in 3 mL of THF was cooled to
-78 °C, and s-BuLi (0.10 mL, 1.53 M, 0.153 mmol) was added. After
5 min of stirring, the golden yellow solution was quench by the rapid
addition of 1 mL of MeOH. The mixture was diluted with CHCl3 (30
mL), washed with 5% HCl (2 × 10 mL) and H2O (10 mL), and dried
(Na2SO4) before removing the solvent in vacuo. The product 6 (>95%
by NMR) exhibited a 1H NMR spectrum identical to material prepared
via TFA-induced cyclization of the terphenyl 2.
5,12-Bis(4-(dodecyloxy)phenyl)dibenz[a,h]anthracene (8). Com-
pound 8 was prepared as described for compound 6, using 3 as the
starting material. Species 8 was isolated as a pale yellow solid in 99.4%
yield (mp 146-149 °C). 1H NMR (250 MHz, CDCl3): δ 0.87 (t, 6H,
J ) 6.8 Hz), 1.1-1.5 (36H), 1.83 (m, 4H), 4.06 (t, 4H, J ) 6.5 Hz),
7.06 (d, 4H, J ) 8.6 Hz), 7.52 (d, 4H, J ) 8.6 Hz), 7.56 (t, 2H, J )
7.9 Hz), 7.70 (t, 2H, J ) 7.9 Hz), 7.88 (s, 2H), 7.97 (d, 2H, 8.1 Hz),
8.91 (d, 2H, J ) 8.3 Hz), 9.14 (s, 2H). 13C NMR (62.9 MHz, CDCl3):
δ 14.1, 22.7, 26.2, 29.4, 29.7, 31.9, 68.2, 114.4, 122.0, 123.1, 126.6,
126.8, 127.1, 127.9, 129.0, 130.4, 130.6, 131.1, 131.7, 132.9, 138.5,
158.7. UV-vis (CHCl3) λmax (ꢀ, cm-1 M-1): 408 (1390), 366 (16 500),
350 (16 600), 314 (55 400), 304 (51 100) nm. Luminescence spectrum
(CHCl3) λmax (rel intensity): 412 (1), 436 (0.61) nm. HRMS (FAB):
found m/z 799.5452 (M + H+); calcd for C58H71O2 m/z 799.5454.
5,12-Bis(4-(dodecyloxy)phenyl)-3,10-dimethoxydibenz[a,h]an-
thracene (9). Compound 9 was prepared as described for compound
6, using compound 4 as the starting material. Species 9 was isolated
as a yellow solid in 98.7% yield (mp 151-154 °C). 1H NMR (250
MHz, CDCl3): δ 0.89 (t, 6H, J ) 6.8 Hz), 1.1-1.5 (36H), 1.85 (m,
4H), 3.81 (s, 6H), 4.04 (t, 4H, J ) 6.40 Hz), 7.04 (d, 4H, 8.72 Hz),
7.30 (dd, 2H, J ) 8.94, 2.62 Hz), 7.37 (d, 2H, J ) 2.55 Hz), 7.50 (d,
4H, J ) 8.67 Hz), 7.81 (s, 2H), 8.77 (d, 2H, J ) 9.06), 8.95 (s, 2H).
13C NMR (62.9 MHz, CDCl3): δ 14.13, 22.70, 26.13, 29.38, 29.48,
29.65, 31.92, 55.32, 68.12, 108.70, 114.39, 115.78, 121.19, 124.59,
124.70, 128.35, 128.52, 129.82, 130.90, 132.93, 132.98, 138.05, 158.37,
158.61. UV-vis (CHCl3) λmax (ꢀ, cm-1 M-1): 410 (2800), 370
(18 100), 322 (98 100), 286 (46 600) nm. Luminescence spectrum
(CHCl3) λmax (rel intensity): 414 (1), 438 (0.55) nm. HRMS (FAB):
found m/z 858.5596 (M+); calcd for C60H74O2 m/z 858.5587.
5,12-Bis(4-(dodecyloxy)phenyl)-1,4,8,11-tetramethyldibenz[a,h]-
anthracene (10). Compound 10 was prepared as described for 6, using
compound 5 as the starting material. Species 10 was isolated as a bright
yellow solid in 98.2% yield (mp 180-184 °C). 1H NMR (250 MHz,
CDCl3): δ 0.89 (t, 6H, J ) 6.83 Hz), 1.1-1.6 (36H), 1.82 (m, 4H),
2.04 (s, 6H), 3.18 (s, 6H), 4.03 (t, 4H, J ) 6.52 Hz), 6.96 (d, 4H, J )
8.67 Hz), 7.25 (d, 2H, J ) 7.50 Hz), 7.33 (d, 4H, J ) 8.56 Hz), 7.42
(d, 2H, J ) 7.50 Hz), 7.69 (s, 2H), 9.06 (s, 2H). 13C NMR (62.9 MHz,
CDCl3): δ 14.15, 22.72, 25.16, 26.14, 26.70, 29.39, 29.48, 29.66, 30.33,
31.95, 68.14, 114.05, 125.53, 127.03, 129.42, 129.57, 130.07, 130.32,
130.89, 131.98, 132.12, 133.22, 133.87, 137.71, 138.43, 158.19. UV-
vis (10-C4 (butoxy replaces docecyloxy), CHCl3) λmax (ꢀ, cm-1 M-1):
418 (2500), 378 (28 800), 364 (27 300), 310 (71 200) nm. Lumines-
cence spectrum (10-C4 (butoxy replaces docecyloxy), CHCl3) λmax (rel
intensity): 426 (1), 448 (0.64) nm. HRMS (FAB): found m/z 854.6031
(M+); calcd for C62H78O2 m/z 854.6002.
1,4-Bis(dibenzo[b,d]thiophen-4-yl)-2,5-bis((4-(dodecyloxy)-
phenyl)ethynyl)benzene (14). Compound 14 was prepared as de-
scribed for compound 2, substituting 4-dibenzothiopheneboronic acid
for 2,5-(dimethoxy)phenylboronic acid. The crude product was crystal-
lized from CHCl3/EtOH. Compound 14 was obtained as a colorless
solid in 86.3% yield (mp 168-169 °C). 1H NMR (500 MHz, CDCl3):
δ 0.86 (t, 6H, J ) 6.8 Hz), 1.2-1.42 (36H), 1.70 (m, 4H), 3.85 (t, 4H,
J ) 6.60 Hz), 6.66 (d, 4H, J ) 8.79 Hz), 6.99 (d, 4H, J ) 8.81 Hz),
7.47 (m, 4H), 7.61 (t, 2H, J ) 7.66 Hz), 7.73 (dd, 2H, J ) 7.37, 1.03
Hz), 7.84 (m, 2H), 7.98 (s, 2H), 8.23 (m, 4H). 13C NMR (125 MHz,
CDCl3, partial): δ 14.10, 22.67, 25.95, 29.12, 29.33, 29.53, 29.56,
29.61, 31.90, 68.00, 87.25, 95.05, 114.37, 114.84, 120.93, 121.69,
122.63, 122.75, 124.29, 126.73, 128.32, 132.85, 133.06, 134.82, 135.84,
General Acid-Induced Cyclization Procedure. 5,12-Bis(4-(dode-
cyloxy)phenyl)-1,4,8,11-tetramethoxydibenz[a,h]anthracene (6). In
a 100 mL Schlenk flask, 2 (0.500 g, 0.544 mmol) was dissolved in 50
mL of CH2Cl2. To the solution was added trifluoroacetic acid (1.5
mL, 19.5 mmol) in one portion at room temperature. The solution
turned in color first to a light red, then to a yellow brown, and finally
1
to a deep green. After 45 min, H NMR indicated the reaction was
complete. The solution was washed with 10% NaHCO3 solution (3 ×
10 mL) and H2O (2 × 15 mL) and dried (Na2SO4). After removal of
the solvent under reduced pressure, the crude product was recrystallized
from benzene. Compound 6 was obtained (0.498 g, 99.6%) as bright
yellow needles (mp 209-211 °C). 1H NMR (250 MHz, CDCl3): δ
0.87 (t, 6H, J ) 6.8 Hz), 1.1-1.5 (36H), 1.83 (m, 4H), 3.43 (s, 6H),
4.03 (t, 4H, J ) 6.5 Hz), 4.13 (s, 6H), 6.94 (d, 4H, J ) 8.6 Hz), 7.03
(d, 2H, J ) 8.8 Hz), 7.18 (d, 2H, J ) 9.0 Hz), 7.34 (d, 4H, J ) 8.5
Hz), 7.78 (s, 2H), 10.10 (s, 2H). 13C NMR (25 MHz, CDCl3): δ 14.0,
22.7, 26.2, 29.3, 29.5, 29.6, 31.9, 56.5, 57.0, 68.4, 110.0, 111.1, 113.3,
122.8, 124.7, 128.0, 128.1, 129.1, 131.1, 132.7, 135.7, 138.9, 151.8,
154.1, 157.5. UV-vis (CHCl3) λmax (ꢀ, cm-1 M-1): 430 (14 400), 406
(12 100), 374 (24 000), 356 (24 600), 318 (55 600), 280 (37 500) nm.
Luminescence spectrum (CHCl3) λmax (rel intensity): 438 (1), 462 (0.53)
nm. HRMS (FAB): found m/z 918.5841 (M+); calcd for C62H78O6
m/z 918.5798 (M+). Anal. Calcd for C62H78O6: C, 81.01; H, 8.55.
Found: C, 80.66; H, 8.65.
5,12-Bis(4-(dodecyloxy)phenyl)-6,13-diiodo-1,4,8,11-tetramethox-
ydibenz[a,h]anthracene (7). To a 50 mL Schlenk tube wrapped with
aluminum foil to omit light and containing I(pyr)2BF4 (0.250 g, 0.672
mmol) was added CH2Cl2 (25 mL), followed by CF3SO3H (60 µL, 6.78
× 10-4 mmol). The solution was allowed to stir at room temperature
for 15 min before being cooled to -40 °C. After this time, 2 (0.300
g, 0.326 mmol) dissolved in CH2Cl2 (10 mL) was added in one portion.
The solution was allowed to warm from -40 to -30 °C over 30 min
and then from -30 to 10 °C over 1.5 h. To the solution were added
50 mL saturated aqueous thiosulfate solution and 50 mL of CHCl3.
The organic layer was washed with an additional portion of thiosulfate
(50 mL) and H2O (2 × 50 mL) and dried (MgSO4). After removal of
solvent under reduced pressure, the crude solid was recrystallized from
THF/MeOH to afford 7 (0.368 g, 96.3%) as a yellow solid (mp 232-
233 °C). 1H NMR (250 MHz, CDCl3): δ 0.88 (t, 6H, J ) 6.7 Hz),
1.1-1.5 (36 H), 1.84 (m, 4H), 3.29 (s, 6H), 4.04 (t, 4H, J ) 6.6 Hz),
4.19 (s, 6H), 6.97 (d, 4H, J ) 8.5 Hz), 6.99 (d, 2H, J ) 8.7), 7.12 (d,
4H, J ) 8.5 Hz), 7.21 (d, 2H, J ) 8.7 Hz), 10.13 (s, 2H). 13C NMR
(25 MHz, CDCl3): δ 14.0, 22.7, 26.2, 29.7, 31.9, 57.3, 57.5, 68.3,
111.4, 111.8, 113.4, 113.5, 122.5, 125.7, 128.7, 129.9, 132.2, 134.9,
142.6, 143.9, 151.1, 153.1, 157.8. UV-vis (CHCl3) λmax (ꢀ, cm-1 M-1):
436 (14 100), 410 (11 000), 380 (16 900), 362 (20 100), 328 (58 800),
284 (42 600) nm. Luminescence spectrum (CHCl3) λmax (rel inten-